in the undescended testes [3] . More recently, an autoimmune mechanism has been suggested to be responsible for cryptorchidism [4] . Medical therapy consists of the administration of human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone (GnRH). With both treatments success rates vary from 10 to 80%. Should the indications 138 Introductory Remarks for medical therapy apply only to testes palpable along the normal pathway of descent, the testis being brought manually to the neck of the scrotum? Should surgery be performed at an early age, at 2 years of age? Surgery before this age results in little improvement in spermatogonial counts [5] . Does it improve fertility? Such surgery is difficult. Before 1 year spontaneous descent can be observed. Should surgery be the first choice and performed immediately if the testes are located high in the inguinal canal or are not palpable? Or should surgery always be secondary to failure of medical therapy? Could medical treatment simplify surgery if the operation takes place quickly after the administration of hCG or GnRH [6]? Evaluation of the results of surgery or hormonal therapy is complicated by disagreements over the definition of cryptorchidism and its clinical assessment. Correct diagnosis of the retractile testis (which is more common than the cryptorchid testis) will avoid unnecessary medical or surgical interference. These are questions that are raised by clinicians in the evaluation of cryptorchidism and the indications for therapy. It is hoped that some of these questions will be answered during this symposium.
